Seoul Pharma Co. Ltd (018680) - Total Liabilities

Latest as of September 2025: ₩32.70 Billion KRW ≈ $22.16 Million USD

Based on the latest financial reports, Seoul Pharma Co. Ltd (018680) has total liabilities worth ₩32.70 Billion KRW (≈ $22.16 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 018680 cash flow conversion to assess how effectively this company generates cash.

Seoul Pharma Co. Ltd - Total Liabilities Trend (2012–2024)

This chart illustrates how Seoul Pharma Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Seoul Pharma Co. Ltd to evaluate the company's liquid asset resilience ratio.

Seoul Pharma Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Seoul Pharma Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Starbreeze AB (publ) ST:STAR-B	Sweden	Skr120.21 Million
Hoftex Group AG MU:NBH	Germany	€66.62 Million
RIAS A/S CO:RIAS-B	Denmark	Dkr56.97 Million
Jullundur Motor Agency (Delhi) Limited NSE:JMA	India	Rs707.50 Million
Condor Resources Inc V:CN	Canada	CA$217.60K
Lyka Labs Limited NSE:LYKALABS	India	Rs664.32 Million
Maternus-Kliniken Aktiengesellschaft F:MAK	Germany	€206.72 Million
Talam Transform Bhd KLSE:2259	Malaysia	RM379.31 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Seoul Pharma Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Seoul Pharma Co. Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.17	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.79	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.44	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Seoul Pharma Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Seoul Pharma Co. Ltd (2012–2024)

The table below shows the annual total liabilities of Seoul Pharma Co. Ltd from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩31.45 Billion ≈ $21.31 Million	+27.11%
2023-12-31	₩24.74 Billion ≈ $16.77 Million	-8.39%
2022-12-31	₩27.01 Billion ≈ $18.30 Million	-37.62%
2021-12-31	₩43.29 Billion ≈ $29.34 Million	+19.48%
2020-12-31	₩36.23 Billion ≈ $24.56 Million	-14.62%
2019-12-31	₩42.44 Billion ≈ $28.76 Million	+5.43%
2018-12-31	₩40.25 Billion ≈ $27.28 Million	+21.70%
2017-12-31	₩33.08 Billion ≈ $22.42 Million	-34.47%
2016-12-31	₩50.47 Billion ≈ $34.20 Million	+2.70%
2015-12-31	₩49.15 Billion ≈ $33.31 Million	+2.65%
2014-12-31	₩47.88 Billion ≈ $32.45 Million	+22.23%
2013-12-31	₩39.17 Billion ≈ $26.55 Million	+10.99%
2012-12-31	₩35.29 Billion ≈ $23.92 Million	--

About Seoul Pharma Co. Ltd

KQ:018680 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$22.28 Million

₩32.88 Billion KRW

Market Cap Rank

#24673 Global

#1823 in Korea

Share Price

₩2820.00

Change (1 day)

-0.70%

52-Week Range

₩2400.00 - ₩3835.00

All Time High

₩17976.69